HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 3,930.00
-50.00 (-1.26%)
At close: May 29, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 112.95 billion as of June 1, 2026. Its market cap has decreased by -12.75% in one year.
Market Cap
112.95B
Enterprise Value
102.16B
Revenue
135.04B
Ranking
n/a
PE Ratio
9.05
Stock Price
3,930.00
Market Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 112.95B, an increase of 344.63%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 117.90B | -8.50% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 148.86B |
| Kyung Dong Pharmaceutical | 140.37B |
| PHARMARESEARCH BIO | 137.76B |
| Vivozon Pharmaceutical | 137.48B |
| Ahn-Gook Pharmaceutical | 130.70B |
| DongKoo Bio & Pharma | 115.47B |
| OPTUS Pharmaceutical | 112.94B |
| H.PIO | 106.08B |